ISIS Pharmaceuticals (ISIS): Q4 EPS of -$0.03. Revenue of $19.9M beats by $4.12M. (PR)

|By:, SA News Editor
ISIS Pharmaceuticals (ISIS): Q4 EPS of -$0.03. Revenue of $19.9M beats by $4.12M. (PR)